Technical consulting services and data analysis of glucagon-like peptide-1 (GLP-1) analogues. Period of performance: september 11, 2023 - september 10, 2024.
Active Purchase Order Awarded Last action
- Contract number
- 75N95023P00761
- Awardee
-
CTR Consulting LLC UEI S4VGJG8BDCD4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $183,257
Award facts
- Opportunity
-
- Technical Consulting Services and Data Analysis of Glucagon-like peptide-1 (GLP-1) analogues as a novel pharmacotherapeutic approach for alcohol use disorder (AUD) Pre-Solicitation · 75N95023Q00552 · Posted Jul 27, 2023
- Contract value 100% obligated
- $183,256.82 Current and potential, with all options
- Completion date 79% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Wilmington, DE 19802, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $43,989 | |
| Other Administrative Action | $0 | |
| Change Order | $41,894 | |
| Exercise an Option | $49,874 | |
| Original award | $47,499 |
About this award
The National Institute on Drug Abuse issued a purchase order to CTR Consulting LLC for $183,256.82 on September 11, 2023, for technical consulting services and data analysis of glucagon-like peptide-1 (GLP-1) analogues as a potential treatment for alcohol use disorder.
Work is performed in Wilmington, Delaware. The order covers data extraction, management, and analysis of a pharmacoepidemiological study examining GLP-1 analogues on alcohol consumption, including development of propensity-score matched models and multivariable linear regression analysis with Alcohol Use Disorders Identification Test—Consumption (AUDIT-C) scoring, and delivery of a final methods and results report. The base period runs from September 11, 2023 through September 10, 2024, with four one-year option periods extending the ultimate completion date to September 10, 2027.
Quick answers
Who was awarded contract 75N95023P00761?
75N95023P00761 was awarded to CTR Consulting LLC by National Institute on Drug Abuse (National Institutes of Health) on September 11, 2023.
How much is contract 75N95023P00761 worth?
The government has obligated $183,257 on 75N95023P00761.
Was contract 75N95023P00761 competed?
The extent of competition for 75N95023P00761 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award